Quantbot Technologies LP reduced its holdings in shares of Masimo Corporation (NASDAQ:MASI) by 11.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,002 shares of the medical equipment provider’s stock after selling 4,036 shares during the period. Quantbot Technologies LP owned approximately 0.06% of Masimo Corporation worth $2,596,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also made changes to their positions in the stock. Alps Advisors Inc. increased its position in Masimo Corporation by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 4,997 shares of the medical equipment provider’s stock valued at $456,000 after buying an additional 13 shares in the last quarter. Sterling Capital Management LLC increased its holdings in shares of Masimo Corporation by 0.6% in the second quarter. Sterling Capital Management LLC now owns 7,803 shares of the medical equipment provider’s stock valued at $711,000 after purchasing an additional 44 shares during the period. Ifrah Financial Services Inc. increased its holdings in shares of Masimo Corporation by 1.2% in the second quarter. Ifrah Financial Services Inc. now owns 4,564 shares of the medical equipment provider’s stock valued at $416,000 after purchasing an additional 53 shares during the period. Hanseatic Management Services Inc. increased its holdings in shares of Masimo Corporation by 1.1% in the second quarter. Hanseatic Management Services Inc. now owns 5,273 shares of the medical equipment provider’s stock valued at $481,000 after purchasing an additional 58 shares during the period. Finally, Dubuque Bank & Trust Co. increased its holdings in shares of Masimo Corporation by 3.4% in the second quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock valued at $170,000 after purchasing an additional 61 shares during the period. 84.94% of the stock is currently owned by institutional investors.

WARNING: “Masimo Corporation (MASI) Position Cut by Quantbot Technologies LP” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another domain, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/11/17/masimo-corporation-masi-position-cut-by-quantbot-technologies-lp.html.

Shares of Masimo Corporation (MASI) traded up $0.12 on Friday, hitting $86.49. The stock had a trading volume of 478,200 shares, compared to its average volume of 628,093. Masimo Corporation has a 1 year low of $60.31 and a 1 year high of $104.71. The stock has a market capitalization of $4,470.00, a P/E ratio of 33.09, a price-to-earnings-growth ratio of 2.91 and a beta of 0.74.

Masimo Corporation (NASDAQ:MASI) last issued its earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 EPS for the quarter, topping analysts’ consensus estimates of $0.53 by $0.17. The firm had revenue of $193.69 million for the quarter, compared to the consensus estimate of $189.01 million. Masimo Corporation had a return on equity of 22.17% and a net margin of 45.83%. The company’s revenue was up 15.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.52 earnings per share. research analysts predict that Masimo Corporation will post 2.95 earnings per share for the current fiscal year.

A number of research analysts have recently weighed in on the company. BidaskClub lowered Masimo Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 31st. BTIG Research raised Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a report on Monday, August 14th. Zacks Investment Research lowered Masimo Corporation from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $108.00 price objective (up from $105.00) on shares of Masimo Corporation in a report on Thursday, August 3rd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the stock. Masimo Corporation currently has an average rating of “Hold” and a consensus target price of $97.17.

In other Masimo Corporation news, EVP Yongsam Lee sold 13,976 shares of the stock in a transaction that occurred on Thursday, November 9th. The stock was sold at an average price of $89.43, for a total transaction of $1,249,873.68. Following the transaction, the executive vice president now owns 74,000 shares in the company, valued at $6,617,820. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Steven Barker sold 10,000 shares of the stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total value of $900,000.00. Following the transaction, the director now owns 73,249 shares in the company, valued at approximately $6,592,410. The disclosure for this sale can be found here. Insiders have sold 28,976 shares of company stock worth $2,599,324 in the last quarter. 16.60% of the stock is currently owned by company insiders.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.